Loading…
Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin
AIM:To investigate the effect of zinc protoporphyrin IX on the response of hepatoma cells to cisplatin and the possible mechanism involved.METHODS:Cytotoxicity was determined using the3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.Apoptosis was determined by a flow cytometric ass...
Saved in:
Published in: | World journal of gastroenterology : WJG 2014-07, Vol.20 (26), p.8572-8582 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c440t-ece8f06d606f317c3501a37e1401c87b0c0371f7b0d2c690bf266e0188aa07773 |
---|---|
cites | |
container_end_page | 8582 |
container_issue | 26 |
container_start_page | 8572 |
container_title | World journal of gastroenterology : WJG |
container_volume | 20 |
creator | Liu, Yang-Sui Li, Huan-Song Qi, Dun-Feng Zhang, Jun Jiang, Xin-Chun Shi, Kui Zhang, Xiao-Jun Zhang, Xin-Hui |
description | AIM:To investigate the effect of zinc protoporphyrin IX on the response of hepatoma cells to cisplatin and the possible mechanism involved.METHODS:Cytotoxicity was determined using the3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.Apoptosis was determined by a flow cytometric assay.Western blotting was used to measure protein expression.Heme oxygenase(HO)-1 activity was measured by determining the level of bilirubin generated in isolated microsomes.Reactive oxygen species(ROS)production was monitored by flow cytometry.Caspase-3 activity was measured with a colorimetric assay kit.Mice were inoculated with 1×107 tumor cells subcutaneously into the right flanks.All mice were sacrificed 6 wk after the first treatment and tumors were weighed and measured.RESULTS:Overexpression of HO-1 in HepG2 cell line was associated with increased chemoresistance to cisdiaminedichloroplatinum(cisplatin;CDDP)compared to other cell lines in vitro.Inhibition of HO-1 expression or activity by zinc protoporphyrin IX(ZnPP IX)markedly augmented CDDP-mediated cytotoxicity towards all liver cancer cell lines in vitro and in vivo.In contrast,induction of HO-1 with hemin increased resistance of tumor cells to CDDP-mediated cytotoxicity in vitro and in vivo.Furthermore,cells treated with ZnPP IX plus CDDP exhibited marked production of intracellular ROS and caspase-3 activity,which paralleled the incidence of cell apoptosis,whereas hemin decreased cellular ROS and caspase-3 activity induced by CDDP.CONCLUSION:ZnPP IX increases cellular sensitivity and susceptibility of liver cancer cell lines to CDDP and this may represent a mechanism of increasing ROS. |
doi_str_mv | 10.3748/wjg.v20.i26.8572 |
format | article |
fullrecord | <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4093706</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><cqvip_id>90888889504849525054485048</cqvip_id><sourcerecordid>25024611</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440t-ece8f06d606f317c3501a37e1401c87b0c0371f7b0d2c690bf266e0188aa07773</originalsourceid><addsrcrecordid>eNpVkE9LJDEQxcOirKO79z0t-QI9Vv50kr4siLgqCF4UZC8hk6mejvQkMWld_Pb2oA67dakq6r1X8CPkB4Ol0NKc_n3cLF84LANXS9Nq_oUsOGddw42EA7JgALrpBNdH5LjWRwAuRMu_kiPeApeKsQV5-BOip7mkKeVU8vBaQqTXDxTj4KLHSv2A2zQNWFzG5yl4WrDmFCvS1NMBs5vS1lGP41jplKgPNY9uCvEbOezdWPH7Rz8h978v7s6vmpvby-vzs5vGSwlTgx5ND2qtQPWCaS9aYE5oZBKYN3oFHoRm_TysuVcdrHquFAIzxjnQWosT8us9Nz-vtrj2GKfiRptL2LryapML9v9LDIPdpBcroRMa1BwA7wG-pFoL9nsvA7ujbGfKdqZsZ8p2R3m2_Pz3597wiXUWiI_MIcXNU4ibvaYDs6uuBWlk186WVkqz28QbG1OLVw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin</title><source>PubMed Central(OpenAccess)</source><creator>Liu, Yang-Sui ; Li, Huan-Song ; Qi, Dun-Feng ; Zhang, Jun ; Jiang, Xin-Chun ; Shi, Kui ; Zhang, Xiao-Jun ; Zhang, Xin-Hui</creator><creatorcontrib>Liu, Yang-Sui ; Li, Huan-Song ; Qi, Dun-Feng ; Zhang, Jun ; Jiang, Xin-Chun ; Shi, Kui ; Zhang, Xiao-Jun ; Zhang, Xin-Hui</creatorcontrib><description>AIM:To investigate the effect of zinc protoporphyrin IX on the response of hepatoma cells to cisplatin and the possible mechanism involved.METHODS:Cytotoxicity was determined using the3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.Apoptosis was determined by a flow cytometric assay.Western blotting was used to measure protein expression.Heme oxygenase(HO)-1 activity was measured by determining the level of bilirubin generated in isolated microsomes.Reactive oxygen species(ROS)production was monitored by flow cytometry.Caspase-3 activity was measured with a colorimetric assay kit.Mice were inoculated with 1×107 tumor cells subcutaneously into the right flanks.All mice were sacrificed 6 wk after the first treatment and tumors were weighed and measured.RESULTS:Overexpression of HO-1 in HepG2 cell line was associated with increased chemoresistance to cisdiaminedichloroplatinum(cisplatin;CDDP)compared to other cell lines in vitro.Inhibition of HO-1 expression or activity by zinc protoporphyrin IX(ZnPP IX)markedly augmented CDDP-mediated cytotoxicity towards all liver cancer cell lines in vitro and in vivo.In contrast,induction of HO-1 with hemin increased resistance of tumor cells to CDDP-mediated cytotoxicity in vitro and in vivo.Furthermore,cells treated with ZnPP IX plus CDDP exhibited marked production of intracellular ROS and caspase-3 activity,which paralleled the incidence of cell apoptosis,whereas hemin decreased cellular ROS and caspase-3 activity induced by CDDP.CONCLUSION:ZnPP IX increases cellular sensitivity and susceptibility of liver cancer cell lines to CDDP and this may represent a mechanism of increasing ROS.</description><identifier>ISSN: 1007-9327</identifier><identifier>EISSN: 2219-2840</identifier><identifier>DOI: 10.3748/wjg.v20.i26.8572</identifier><identifier>PMID: 25024611</identifier><language>eng</language><publisher>United States: Baishideng Publishing Group Inc</publisher><subject>Animals ; Antineoplastic Combined Chemotherapy Protocols - pharmacology ; Apoptosis - drug effects ; canc ; Carcinoma, Hepatocellular - drug therapy ; Carcinoma, Hepatocellular - metabolism ; Carcinoma, Hepatocellular - pathology ; Caspase 3 - metabolism ; Cisplatin - administration & dosage ; Dose-Response Relationship, Drug ; Drug Resistance, Neoplasm ; Female ; Heme ; Heme Oxygenase-1 - metabolism ; Hemin - pharmacology ; Hep G2 Cells ; Humans ; Liver ; Liver Neoplasms - drug therapy ; Liver Neoplasms - metabolism ; Liver Neoplasms - pathology ; Mice, Nude ; Original ; Oxidative Stress - drug effects ; oxygenase-1 ; protoporphyrin ; Protoporphyrins - administration & dosage ; Reactive Oxygen Species - metabolism ; Time Factors ; Tumor Burden - drug effects ; Xenograft Model Antitumor Assays ; Zinc</subject><ispartof>World journal of gastroenterology : WJG, 2014-07, Vol.20 (26), p.8572-8582</ispartof><rights>2014 Baishideng Publishing Group Inc. All rights reserved. 2014</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440t-ece8f06d606f317c3501a37e1401c87b0c0371f7b0d2c690bf266e0188aa07773</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Uhttp://image.cqvip.com/vip1000/qk/84123X/84123X.jpg</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093706/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093706/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25024611$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Yang-Sui</creatorcontrib><creatorcontrib>Li, Huan-Song</creatorcontrib><creatorcontrib>Qi, Dun-Feng</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><creatorcontrib>Jiang, Xin-Chun</creatorcontrib><creatorcontrib>Shi, Kui</creatorcontrib><creatorcontrib>Zhang, Xiao-Jun</creatorcontrib><creatorcontrib>Zhang, Xin-Hui</creatorcontrib><title>Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin</title><title>World journal of gastroenterology : WJG</title><addtitle>World Journal of Gastroenterology</addtitle><description>AIM:To investigate the effect of zinc protoporphyrin IX on the response of hepatoma cells to cisplatin and the possible mechanism involved.METHODS:Cytotoxicity was determined using the3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.Apoptosis was determined by a flow cytometric assay.Western blotting was used to measure protein expression.Heme oxygenase(HO)-1 activity was measured by determining the level of bilirubin generated in isolated microsomes.Reactive oxygen species(ROS)production was monitored by flow cytometry.Caspase-3 activity was measured with a colorimetric assay kit.Mice were inoculated with 1×107 tumor cells subcutaneously into the right flanks.All mice were sacrificed 6 wk after the first treatment and tumors were weighed and measured.RESULTS:Overexpression of HO-1 in HepG2 cell line was associated with increased chemoresistance to cisdiaminedichloroplatinum(cisplatin;CDDP)compared to other cell lines in vitro.Inhibition of HO-1 expression or activity by zinc protoporphyrin IX(ZnPP IX)markedly augmented CDDP-mediated cytotoxicity towards all liver cancer cell lines in vitro and in vivo.In contrast,induction of HO-1 with hemin increased resistance of tumor cells to CDDP-mediated cytotoxicity in vitro and in vivo.Furthermore,cells treated with ZnPP IX plus CDDP exhibited marked production of intracellular ROS and caspase-3 activity,which paralleled the incidence of cell apoptosis,whereas hemin decreased cellular ROS and caspase-3 activity induced by CDDP.CONCLUSION:ZnPP IX increases cellular sensitivity and susceptibility of liver cancer cell lines to CDDP and this may represent a mechanism of increasing ROS.</description><subject>Animals</subject><subject>Antineoplastic Combined Chemotherapy Protocols - pharmacology</subject><subject>Apoptosis - drug effects</subject><subject>canc</subject><subject>Carcinoma, Hepatocellular - drug therapy</subject><subject>Carcinoma, Hepatocellular - metabolism</subject><subject>Carcinoma, Hepatocellular - pathology</subject><subject>Caspase 3 - metabolism</subject><subject>Cisplatin - administration & dosage</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug Resistance, Neoplasm</subject><subject>Female</subject><subject>Heme</subject><subject>Heme Oxygenase-1 - metabolism</subject><subject>Hemin - pharmacology</subject><subject>Hep G2 Cells</subject><subject>Humans</subject><subject>Liver</subject><subject>Liver Neoplasms - drug therapy</subject><subject>Liver Neoplasms - metabolism</subject><subject>Liver Neoplasms - pathology</subject><subject>Mice, Nude</subject><subject>Original</subject><subject>Oxidative Stress - drug effects</subject><subject>oxygenase-1</subject><subject>protoporphyrin</subject><subject>Protoporphyrins - administration & dosage</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Time Factors</subject><subject>Tumor Burden - drug effects</subject><subject>Xenograft Model Antitumor Assays</subject><subject>Zinc</subject><issn>1007-9327</issn><issn>2219-2840</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNpVkE9LJDEQxcOirKO79z0t-QI9Vv50kr4siLgqCF4UZC8hk6mejvQkMWld_Pb2oA67dakq6r1X8CPkB4Ol0NKc_n3cLF84LANXS9Nq_oUsOGddw42EA7JgALrpBNdH5LjWRwAuRMu_kiPeApeKsQV5-BOip7mkKeVU8vBaQqTXDxTj4KLHSv2A2zQNWFzG5yl4WrDmFCvS1NMBs5vS1lGP41jplKgPNY9uCvEbOezdWPH7Rz8h978v7s6vmpvby-vzs5vGSwlTgx5ND2qtQPWCaS9aYE5oZBKYN3oFHoRm_TysuVcdrHquFAIzxjnQWosT8us9Nz-vtrj2GKfiRptL2LryapML9v9LDIPdpBcroRMa1BwA7wG-pFoL9nsvA7ujbGfKdqZsZ8p2R3m2_Pz3597wiXUWiI_MIcXNU4ibvaYDs6uuBWlk186WVkqz28QbG1OLVw</recordid><startdate>20140714</startdate><enddate>20140714</enddate><creator>Liu, Yang-Sui</creator><creator>Li, Huan-Song</creator><creator>Qi, Dun-Feng</creator><creator>Zhang, Jun</creator><creator>Jiang, Xin-Chun</creator><creator>Shi, Kui</creator><creator>Zhang, Xiao-Jun</creator><creator>Zhang, Xin-Hui</creator><general>Baishideng Publishing Group Inc</general><scope>2RA</scope><scope>92L</scope><scope>CQIGP</scope><scope>W91</scope><scope>~WA</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20140714</creationdate><title>Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin</title><author>Liu, Yang-Sui ; Li, Huan-Song ; Qi, Dun-Feng ; Zhang, Jun ; Jiang, Xin-Chun ; Shi, Kui ; Zhang, Xiao-Jun ; Zhang, Xin-Hui</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440t-ece8f06d606f317c3501a37e1401c87b0c0371f7b0d2c690bf266e0188aa07773</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Animals</topic><topic>Antineoplastic Combined Chemotherapy Protocols - pharmacology</topic><topic>Apoptosis - drug effects</topic><topic>canc</topic><topic>Carcinoma, Hepatocellular - drug therapy</topic><topic>Carcinoma, Hepatocellular - metabolism</topic><topic>Carcinoma, Hepatocellular - pathology</topic><topic>Caspase 3 - metabolism</topic><topic>Cisplatin - administration & dosage</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug Resistance, Neoplasm</topic><topic>Female</topic><topic>Heme</topic><topic>Heme Oxygenase-1 - metabolism</topic><topic>Hemin - pharmacology</topic><topic>Hep G2 Cells</topic><topic>Humans</topic><topic>Liver</topic><topic>Liver Neoplasms - drug therapy</topic><topic>Liver Neoplasms - metabolism</topic><topic>Liver Neoplasms - pathology</topic><topic>Mice, Nude</topic><topic>Original</topic><topic>Oxidative Stress - drug effects</topic><topic>oxygenase-1</topic><topic>protoporphyrin</topic><topic>Protoporphyrins - administration & dosage</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Time Factors</topic><topic>Tumor Burden - drug effects</topic><topic>Xenograft Model Antitumor Assays</topic><topic>Zinc</topic><toplevel>online_resources</toplevel><creatorcontrib>Liu, Yang-Sui</creatorcontrib><creatorcontrib>Li, Huan-Song</creatorcontrib><creatorcontrib>Qi, Dun-Feng</creatorcontrib><creatorcontrib>Zhang, Jun</creatorcontrib><creatorcontrib>Jiang, Xin-Chun</creatorcontrib><creatorcontrib>Shi, Kui</creatorcontrib><creatorcontrib>Zhang, Xiao-Jun</creatorcontrib><creatorcontrib>Zhang, Xin-Hui</creatorcontrib><collection>维普_期刊</collection><collection>中文科技期刊数据库-CALIS站点</collection><collection>维普中文期刊数据库</collection><collection>中文科技期刊数据库-医药卫生</collection><collection>中文科技期刊数据库- 镜像站点</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>World journal of gastroenterology : WJG</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Yang-Sui</au><au>Li, Huan-Song</au><au>Qi, Dun-Feng</au><au>Zhang, Jun</au><au>Jiang, Xin-Chun</au><au>Shi, Kui</au><au>Zhang, Xiao-Jun</au><au>Zhang, Xin-Hui</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin</atitle><jtitle>World journal of gastroenterology : WJG</jtitle><addtitle>World Journal of Gastroenterology</addtitle><date>2014-07-14</date><risdate>2014</risdate><volume>20</volume><issue>26</issue><spage>8572</spage><epage>8582</epage><pages>8572-8582</pages><issn>1007-9327</issn><eissn>2219-2840</eissn><abstract>AIM:To investigate the effect of zinc protoporphyrin IX on the response of hepatoma cells to cisplatin and the possible mechanism involved.METHODS:Cytotoxicity was determined using the3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay.Apoptosis was determined by a flow cytometric assay.Western blotting was used to measure protein expression.Heme oxygenase(HO)-1 activity was measured by determining the level of bilirubin generated in isolated microsomes.Reactive oxygen species(ROS)production was monitored by flow cytometry.Caspase-3 activity was measured with a colorimetric assay kit.Mice were inoculated with 1×107 tumor cells subcutaneously into the right flanks.All mice were sacrificed 6 wk after the first treatment and tumors were weighed and measured.RESULTS:Overexpression of HO-1 in HepG2 cell line was associated with increased chemoresistance to cisdiaminedichloroplatinum(cisplatin;CDDP)compared to other cell lines in vitro.Inhibition of HO-1 expression or activity by zinc protoporphyrin IX(ZnPP IX)markedly augmented CDDP-mediated cytotoxicity towards all liver cancer cell lines in vitro and in vivo.In contrast,induction of HO-1 with hemin increased resistance of tumor cells to CDDP-mediated cytotoxicity in vitro and in vivo.Furthermore,cells treated with ZnPP IX plus CDDP exhibited marked production of intracellular ROS and caspase-3 activity,which paralleled the incidence of cell apoptosis,whereas hemin decreased cellular ROS and caspase-3 activity induced by CDDP.CONCLUSION:ZnPP IX increases cellular sensitivity and susceptibility of liver cancer cell lines to CDDP and this may represent a mechanism of increasing ROS.</abstract><cop>United States</cop><pub>Baishideng Publishing Group Inc</pub><pmid>25024611</pmid><doi>10.3748/wjg.v20.i26.8572</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1007-9327 |
ispartof | World journal of gastroenterology : WJG, 2014-07, Vol.20 (26), p.8572-8582 |
issn | 1007-9327 2219-2840 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4093706 |
source | PubMed Central(OpenAccess) |
subjects | Animals Antineoplastic Combined Chemotherapy Protocols - pharmacology Apoptosis - drug effects canc Carcinoma, Hepatocellular - drug therapy Carcinoma, Hepatocellular - metabolism Carcinoma, Hepatocellular - pathology Caspase 3 - metabolism Cisplatin - administration & dosage Dose-Response Relationship, Drug Drug Resistance, Neoplasm Female Heme Heme Oxygenase-1 - metabolism Hemin - pharmacology Hep G2 Cells Humans Liver Liver Neoplasms - drug therapy Liver Neoplasms - metabolism Liver Neoplasms - pathology Mice, Nude Original Oxidative Stress - drug effects oxygenase-1 protoporphyrin Protoporphyrins - administration & dosage Reactive Oxygen Species - metabolism Time Factors Tumor Burden - drug effects Xenograft Model Antitumor Assays Zinc |
title | Zinc protoporphyrin IX enhances chemotherapeutic response of hepatoma cells to cisplatin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T10%3A29%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Zinc%20protoporphyrin%20IX%20enhances%20chemotherapeutic%20response%20of%20hepatoma%20cells%20to%20cisplatin&rft.jtitle=World%20journal%20of%20gastroenterology%20:%20WJG&rft.au=Liu,%20Yang-Sui&rft.date=2014-07-14&rft.volume=20&rft.issue=26&rft.spage=8572&rft.epage=8582&rft.pages=8572-8582&rft.issn=1007-9327&rft.eissn=2219-2840&rft_id=info:doi/10.3748/wjg.v20.i26.8572&rft_dat=%3Cpubmed_cross%3E25024611%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c440t-ece8f06d606f317c3501a37e1401c87b0c0371f7b0d2c690bf266e0188aa07773%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/25024611&rft_cqvip_id=90888889504849525054485048&rfr_iscdi=true |